You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Granulocyte Colony-Stimulating Factor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

Not yet recruiting
  • Leukemia, Acute Myeloid (AML)
  • (no location specified)
Oct 16, 2022

Alcoholic Hepatitis Trial in Chuncheon (G-CSF (Filgrastim injection), steroid, )

Terminated
  • Alcoholic Hepatitis
  • G-CSF (Filgrastim injection)
  • +2 more
  • Chuncheon, Korea, Republic of
    Chuncheon Sacred Heart hospital
Aug 4, 2022

Clinical Specimen Collection From Pompe Disease Patients

Recruiting
  • Pompe Disease
  • Toluca Lake, California
    Seraph Research Institute
May 17, 2022

Frailty Trial in Boynton Beach (GMFFP)

Enrolling by invitation
  • Frailty
  • Boynton Beach, Florida
    South Florida Bone Marrow/Stem Cell Transplant Institute DBA Mah
May 5, 2022

Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

Recruiting
  • Acute Myeloid Leukemia
  • Graft cell infusion
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 29, 2023

Early Stage Breast Cancer Trial in United States (Paclitaxel, Neulasta)

Completed
Has Results
  • Early Stage Breast Cancer
  • Boston, Massachusetts
  • +3 more
Apr 11, 2022

Cervix Cancer, Endometrial Cancer Trial in Stanford (FDG PET/CT, GCSF)

Recruiting
  • Cervix Cancer
  • Endometrial Cancer
  • Stanford, California
    Stanford Cancer Institute Palo Alto
Feb 11, 2022

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Healthy Trial run by the NHLBI (AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF))

Completed
Has Results
  • Healthy
  • AMD 3100 (Mozobil plerixafor)
  • Granulocyte colony-stimulating factor (G-CSF)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2021

Pediatric Cancer Trial in Guangzhou (pegylated recombinant human granulocyte-colony stimulating factor)

Recruiting
  • Pediatric Cancer
  • pegylated recombinant human granulocyte-colony stimulating factor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center,
Aug 27, 2021

Premature Ovarian Failure Trial (Filgrastim, Saline)

Completed
  • Premature Ovarian Failure
  • (no location specified)
Sep 20, 2021

Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)

Completed
Has Results
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 23, 2022

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Neuroblastoma Trial in Minneapolis (drug, biological, radiation)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)

Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
Dec 22, 2022

Neuroblastoma Trial in New York (Hu3F8 With GM-CSF)

Active, not recruiting
  • Neuroblastoma
  • Hu3F8 With GM-CSF
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 2, 2022

Increase Muscle Strength in Patients With Muscular Dystrophy Trial in Bialystok (Granulocyte colony-stimulating factor

Unknown status
  • Increase Muscle Strength in Patients With Muscular Dystrophy
  • Granulocyte colony-stimulating factor (Filgrastim)
  • Białystok, Podlaskie, Poland
    Department of Pediatric Rehabilitation
Feb 12, 2021

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Granulocyte Colony-Stimulating Factor, PD-1 Inhibitor Trial in Guangzhou (PEG-rhG-CSF)

Recruiting
  • Granulocyte Colony-Stimulating Factor
  • PD-1 Inhibitor
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
Has Results
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 10, 2022

Anterior Myocardial Infarction, Heart Failure Trial in Rome (rhu G-CSF, optimal standard of care, Myocardial Contrast

Withdrawn
  • Anterior Myocardial Infarction
  • Heart Failure
  • rhu G-CSF
  • +2 more
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli
Mar 28, 2022